Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

221.91 USD -2.03 (-0.91%)
Official Closing Price Updated: 7:59 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,577,000
Open 227.82
Bid (Size) 221.38 (1)
Ask (Size) 225.24 (1)
Prev. Close 223.94
Today's Range 220.25 - 227.87
52wk Range 177.05 - 276.69
Shares Outstanding 661,706,000
Dividend Yield 3.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime Therapeutics, Inc. ("Five Prime" or the "Company") (NASDAQ: FPRX)... 
From PR Newswire
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-In-Class Program For Gastric Cancer, the Third Leading Cause of Cancer Mortality Worldwide 
From PR Newswire

Performance

YTD
-2.10%
-2.10%
1 Month
-7.73%
-7.73%
3 Month
-2.21%
-2.21%
6 Month
-10.49%
-10.49%
1 Year
+3.16%
+3.16%

More News

Read More
FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Amgen Announces 2021 Second Quarter Dividend
From PR Newswire
BLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
From PR Newswire
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
From PR Newswire
Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash
From Business Wire News Releases
Amgen Becomes Oversold (AMGN)
Tags Stocks
From Market News Video
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher
Tags NASDAQ:FPRX,NASDAQ:AMGN Market News Today's Market
From InvestorPlace
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
Tags News Biotech General
From Benzinga
Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion
Tags AMGN FPRX Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.